The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
https://www.sharesoc.org/events/shares-investor-webinar1-december-2021/
Ok, why another webinar and why so soon?
Thanks for the breakdown
I joined but it looks empty.
So what’s going on? You think a new investor on existing shares rather than a possible dilution?
https://www.benzinga.com/news/21/05/20972632/midatech-shares-spike-higher-as-traders-circulate-european-patent-office-specification-for-co-s-nano
Basically it says There is a rumor of another patent this one for NANOPARTICLE-BASED LIVER-TARGETING THERAPY'.
If you are referring to the UCSF study, this reported in October. The Phase II study at Columbia will start next quarter.
Rgds
SAS
Y’all see that the anti rejection and CNS drugs have been named?
So MTD201 has disappeared from the pipeline on the website. Interesting, does anyone have any theories? If I remember correctly we were just waiting for a partner for phase III on this potential 25 billion drug.
I have been so confused about this with the Clinical Trials.gov site saying something totally different.
https://clinicaltrials.gov/ct2/show/NCT03566199?term=Mtx110&draw=2&rank=1
Anyone know about how long after trial completion we should see results? This is now marked complete phase I and II, last update April 12th. Tapping my foot.
Look at the issue date ate the top. April 21st. This is for the printing method and is very important.
Ok website updated and notice slight change in clinical trial info from MTX110 -
ClinicalTrials.gov Identifier: NCT03566199
Recruitment Status : Completed
First Posted : June 25, 2018
Last Update Posted : April 13, 2021
I’m thinking good things.
Thanks. We are so due for some news.
Do ya’ll think the MTX’s are formulations of Methotrexate ? Also I kinda think Pfizer is the mystery pharma. What do you think?
https://clinicaltrials.ucsf.edu/trial/NCT03566199
I am so confused. Looking at the Midatech website it appears that phase II hasn’t staerted yet but looking at this results are due. Does anyone have any clarity?
That was the weakest announcement for an agreement I think I’ve ever read. Didn’t even name the other company. It was very oddly worded, very lawyerly.
I’m confused, clinicaltrial.gov has results for phase I,II MTX110 due by the end of the month but everything on the site says phase II hasn’t even started. Can anyone help me understand?
So let’s say the fast tracked MTX-110 trial reports good results and we move on to a new drug application. How long does that take.